Home ILMN
208.70
  Price2.59%   -5.56
(After Hours: 209.71 +1.01 +0.48% )
loading

Illumina, Inc. (ILMN) Latest News

Feb-02-23 10:00AM Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research
Jan-31-23 10:00AM Analysts Estimate Illumina (ILMN) to Report a Decline in Earnings: What to Look Out forZacks Investment Research
Jan-30-23 12:27PM Tracking Baillie Gifford's 13F Portfolio - Q4 2022 UpdateSeeking Alpha
Jan-26-23 10:08AM What's in the Cards for Illumina (ILMN) in Q4 Earnings?Zacks Investment Research
Jan-25-23 10:01AM 7 Analysts Have This to Say About IlluminaBenzinga
10:01AM Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2023Benzinga
Jan-19-23 07:39AM These 4 Toxic Stocks May Bring Bad Luck to Your PortfolioZacks Investment Research
Jan-10-23 03:02AM Illumina Shares Tank After Annual Guidance Fall Short Of ExpectationsBenzinga
10:17AM Illumina (ILMN), Nashville Biosciences Partner With AmgenZacks Investment Research
Jan-10-23 06:11AM US Stocks Show Tentativeness On Tuesday As Traders Wait On Word From Fed Chair Jerome PowellBenzinga
Jan-05-23 10:01AM Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023Benzinga
Jan-04-23 07:35AM New Strong Sell Stocks for January 4thZacks Investment Research
07:06AM 5 Toxic Stocks That Can Set Off Alarm Bells for Your PortfolioZacks Investment Research
Dec-30-22 10:19AM Are Options Traders Betting on a Big Move in Illumina (ILMN) Stock?Zacks Investment Research
Dec-14-22 10:57AM Is Illumina Cheap or Expensive?The Motley Fool
Dec-12-22 10:01AM Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022Benzinga
Dec-05-22 12:23PM Tracking Al Gore's Generation Investment Management Portfolio - Q3 2022 UpdateSeeking Alpha
Nov-14-22 08:58AM Amazon To $103? Plus Piper Sandler Predicts $300 For IlluminaBenzinga
Nov-07-22 12:18PM What 12 Analyst Ratings Have To Say About IlluminaBenzinga
Nov-04-22 03:13AM 11 Analysts Have This to Say About IlluminaBenzinga
Oct-27-22 10:02AM Illumina (ILMN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research
09:05AM Wall Street Is Still Bullish on This Punished Growth Stock -- Is It a Buy?The Motley Fool
Oct-25-22 09:39AM What's in the Cards for Illumina (ILMN) in Q3 Earnings?Zacks Investment Research
Oct-24-22 10:10AM PacBio's (PACB) Latest Offering to Enhance Genome SequencingZacks Investment Research
Oct-18-22 07:36AM This Growth Stock Rose Last Week. Is It Still a Buy?The Motley Fool
Oct-10-22 12:10PM Big-Cap S&P Stocks Will Soon Provide Tech-Like Returns, I ExplainSeeking Alpha
Oct-05-22 03:37AM Is Illumina Still The Gamechanger In Genomic Sequencing?Investing.com
03:15AM Twitter, Ford And Other Big Gainers From TuesdayBenzinga
Oct-04-22 12:32PM Why This Illumina Analyst Is Bullish About NovaSeq X+Benzinga
10:30AM Benzinga's Top Ratings Upgrades, Downgrades For October 4, 2022Benzinga
Sep-30-22 01:09AM 12 Analysts Have This to Say About IlluminaBenzinga
11:04AM What 12 Analyst Ratings Have To Say About IlluminaBenzinga
Sep-29-22 03:45AM Netflix, Biogen And Other Big Gainers From WednesdayBenzinga
Sep-28-22 10:01AM Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022Benzinga
Sep-13-22 01:06AM 20 value stocks whose growth potential is overlooked by investorsMarketWatch
06:30AM 20 value stocks whose growth potential is overlooked by investorsMarketWatch
Sep-12-22 02:09AM 20 value stocks whose growth potential is overlooked by investorsMarketWatch
Sep-07-22 09:33AM Company News for Sep 7, 2022Zacks Investment Research
Sep-02-22 10:53AM Is Illumina a Buy?The Motley Fool
09:20AM Got $10,000? Consider Buying the Dip on This Monster Growth StockThe Motley Fool
Sep-01-22 09:00AM Here is What to Know Beyond Why Illumina, Inc. (ILMN) is a Trending StockZacks Investment Research
Aug-25-22 10:34AM Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022Benzinga
05:29AM Dow, Nasdaq Futures Surge Ahead Of Jackson Hole SymposiumBenzinga
Aug-18-22 10:53AM 2 Red Flags and 1 Green Flag For Illumina StockThe Motley Fool
09:00AM Is Trending Stock Illumina, Inc. (ILMN) a Buy Now?Zacks Investment Research
Aug-17-22 07:30AM Top Buys From The Best Money Managers (Q2 2022)Seeking Alpha
Aug-16-22 09:29AM Stock Market News for Aug 16, 2022Zacks Investment Research
03:28AM This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From YesterdayBenzinga
Aug-15-22 01:02AM Snap, Gilead Sciences And Some Other Big Stocks Moving Higher On MondayBenzinga
12:05PM Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day SessionBenzinga
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs. It offers sequencing by synthesis technology that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow the detection of known genetic markers on a single array. The company also provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and noninvasive prenatal testing, as well as products support services. It serves genomic research centers, academic institutions, government laboratories, and hospitals; and pharmaceutical, biotechnology, agrigenomics, and commercial molecular diagnostic laboratories, as well as consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. It operates in North America, Europe, Latin America, the Asia-Pacific region, the Middle East, and South Africa. The company has a strategic partnership with Loxo Oncology, Inc. to develop and commercialize a multi-gene panel for broad tumor profiling; and strategic collaboration with Bristol-Myers Squibb Company. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Cap:    |  Volume (24h):